Dr Stuart Quin appointed as Chief Executive Officer
9th May 2019
Medica Group Plc, the UK market leader in the provision of teleradiology services, announces that Dr Stuart Quin has been appointed as Chief Executive Officer. Dr Quin will join Medica and its Board of Directors on 1 September 2019. John Graham will remain as Chief Executive Officer until Dr Quin joins the company ensuring a smooth transition.
Stuart will join Medica from Synlab, the international laboratory diagnostic services provider, where he is currently Head of Central and Eastern Europe, Middle East and Africa. Previously he was Synlab’s Group Chief Commercial Officer and Chief Executive of its UK operations. Stuart brings a track record of delivering significant growth both in the UK and internationally and has extensive experience of working in partnership with the NHS. During Stuart’s tenure in the UK he expanded the business by winning new diagnostic service contracts and through the acquisition of four companies that significantly diversified Synlab’s service offering for customers. Prior to joining Synlab, Stuart worked in private equity both as an Investment Director at August Equity and for seven years at 3i in the UK and Germany as an Associate Director focusing on investing in healthcare. Stuart also spent four years at Accenture in the US and UK as a Manager in the health and life sciences strategy consulting practice. Stuart holds a BSc (Hons) in immunology from the University of Edinburgh, a PhD in immunology from Imperial College London and an MBA from INSEAD.
Roy Davis, Chairman of Medica, commented:
“I am delighted that Stuart will be joining Medica Group as Chief Executive Officer. We undertook a rigourous recruitment process and the Board believe that Stuart is ideally suited to lead Medica as we look to continue the high growth of our business both in the UK and overseas. Stuart brings extensive experience of providing a breadth of diagnostic services to the UK’s National Health Service and to independent sector customers, as well as a background in strategic leadership of an international healthcare business.”
Commenting on his appointment, Stuart Quin said:
“I am honoured to have the opportunity to lead Medica through the next phase of its development. The company has a strong reputation of delivering teleradiology services to NHS trusts across the UK. I am looking forward to working with the team at Medica, to identify and execute new growth opportunities and continuing to offer the highest quality service for customers.”
For further information, please contact:
Medica Group Plc: Paul Cornell +44 (0)1424 377 905
FTI Consulting: Robert Winder +44 (0)20 3727 1000